SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Noven Pharmaceuticals (NOVN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (7)8/29/1997 9:48:00 AM
From: Todd D. Wiener   of 66
 
John-

It's interesting that they stuffed the channels so much that it would affect sales nearly a year later. That indeed indicates that the end-market demand wasn't as great as they all had hoped.

I think that if dentists are made aware of DentiPatch, it will sell itself.

I am a former RPR shareholder. I know that the ERT/HRT products are important to RPR. Their equity stake in NOVN indicates their interest/confidence/whatever. I think things will get better as time passes.

Todd
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News